Search research articles
Contact Us
Filters
Showing results (221-230 of 294) with videos related to
Page
of 30
Sort By:
British Journal of Haematology
|
November 18, 2021
Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells
Helal Mohammed Mohammed Ahmed, Subbaiah Chary Nimmagadda, Yahya S Al-Matary, et al.
The Lancet. Haematology
|
August 27, 2021
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial
Anna-Katharina Zoellner, Michael Unterhalt, Stephan Stilgenbauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 1, 2026
Prognostic role of FDG-PET in patients with relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies: a multicentric analysis
Sophie Wollnitza, David Ventura, Marcel Teichert, et al.
The EMBO Journal
|
August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors
Pia Riemke, Melinda Czeh, Josephine Fischer, et al.
Cancers
|
August 12, 2022
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis
Evgenii Shumilov, Lena Aperdannier, Nicole Schmidt, et al.
Blood
|
April 28, 2010
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M Hartmann, Elias Campo, George Wright, et al.
Blood Advances
|
April 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
Andrew F Berdel, Leo Ruhnke, Linus Angenendt, et al.
Oncogene
|
February 27, 2022
Targeted siRNA nanocarrier: a platform technology for cancer treatment
Nicole Bäumer, Jessica Tiemann, Annika Scheller, et al.
Cancer Cell
|
August 19, 2007
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma
Christina M Annunziata, R Eric Davis, Yulia Demchenko, et al.
American Journal of Hematology
|
December 24, 2019
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study
Martin Dreyling, Armando Santoro, Luigina Mollica, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 294) with videos related to
Sort By:
Page
of 30
British Journal of Haematology
|
November 18, 2021
Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells
Helal Mohammed Mohammed Ahmed, Subbaiah Chary Nimmagadda, Yahya S Al-Matary, et al.
The Lancet. Haematology
|
August 27, 2021
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial
Anna-Katharina Zoellner, Michael Unterhalt, Stephan Stilgenbauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 1, 2026
Prognostic role of FDG-PET in patients with relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies: a multicentric analysis
Sophie Wollnitza, David Ventura, Marcel Teichert, et al.
The EMBO Journal
|
August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors
Pia Riemke, Melinda Czeh, Josephine Fischer, et al.
Cancers
|
August 12, 2022
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis
Evgenii Shumilov, Lena Aperdannier, Nicole Schmidt, et al.
Blood
|
April 28, 2010
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M Hartmann, Elias Campo, George Wright, et al.
Blood Advances
|
April 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
Andrew F Berdel, Leo Ruhnke, Linus Angenendt, et al.
Oncogene
|
February 27, 2022
Targeted siRNA nanocarrier: a platform technology for cancer treatment
Nicole Bäumer, Jessica Tiemann, Annika Scheller, et al.
Cancer Cell
|
August 19, 2007
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma
Christina M Annunziata, R Eric Davis, Yulia Demchenko, et al.
American Journal of Hematology
|
December 24, 2019
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study
Martin Dreyling, Armando Santoro, Luigina Mollica, et al.
Page
of 30